Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-adrenergic blockade. An update.

W H Frishman, M Teicher

    Cardiology
    |January 1, 1985
    PubMed
    Summary

    Beta-blockers are a significant pharmaceutical advancement, blocking adrenergic receptors to counteract catecholamine effects. These versatile drugs are safe and effective for numerous cardiovascular and noncardiovascular conditions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    AIDS and the heart: Clinicopathologic assessment.

    Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
    Same author

    Time-frequency characterization of electrocorticographic recordings of epileptic patients using frequency-entropy similarity: a comparison to other bi-variate measures.

    Journal of neuroscience methods·2010
    Same author

    ACE inhibitors and the arterial wall. Introduction.

    Postgraduate medicine·2009
    Same author

    Pathophysiology and medical management of systemic hypertension and pre-eclampsia in pregnancy.

    Minerva medica·2006
    Same author

    Antiplatelet therapy: glycoprotein IIb/IIIa receptor antagonists.

    Drugs of today (Barcelona, Spain : 1998)·2003
    Same author

    Alcohol as a cardioprotective agent.

    Heart disease (Hagerstown, Md.)·2002

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine
    • Adrenergic Receptor Antagonists

    Background:

    • Beta-adrenergic blockade is a major pharmacologic advance.
    • Beta-blockers interact with membrane adrenergic receptors, antagonizing endogenous catecholamines.
    • Eight beta-blockers are currently available in the U.S., with more under investigation.

    Purpose of the Study:

    • To review the pharmacodynamic and pharmacokinetic properties of beta-blockers.
    • To discuss the therapeutic applications and safety of beta-blockers.
    • To highlight the role of the sympathetic nervous system in disease pathophysiology.

    Main Methods:

    • Literature review of existing studies on beta-blockers.
    • Analysis of pharmacodynamic properties including selectivity, partial agonism, and alpha-blocking activity.
    • Evaluation of pharmacokinetic characteristics and clinical outcomes.

    Main Results:

    • Beta-blockers exhibit diverse pharmacodynamic and pharmacokinetic profiles.
    • These properties can influence side effect profiles.
    • The drugs demonstrate safety and efficacy across a broad range of conditions.

    Conclusions:

    • Beta-blockers are valuable therapeutic agents.
    • Their varied properties allow for tailored patient treatment.
    • The efficacy of beta-blockers underscores the importance of the sympathetic nervous system in illness.

    Related Experiment Videos